UnknownPhase 4

Oral Administration of Tranexamic Acid in Anterior Cruciate Ligament Surgery Reduce Postoperative Haemarthrosis

Belgium104 participantsStarted 2021-07-06

Plain-language summary

To find superiority relationship between oral and intravenous administration of tranexamic acid on peroperative and postoperative blood loss, haemarthrosis prevalence and improvement functional prognosis in anterior cruciate ligament arthroscopy.

Who can participate

Age range18 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Primary arthroscopic surgery for anterior cruciate ligament reconstruction Exclusion Criteria: * Renal failure with serum creatinine level higher than 1,40 mg/dL * Thromboembolic events in last 12 months before surgery * Pregnancy * Congenital or acquired coagulation diseases * History of gastric surgery that could lead to malabsorption * Diabetic gastro-paresis

What they're measuring

Assessment of haemarthrosis

Timeframe: First 24 hours after surgery

Trial details

NCT IDNCT04855877

SponsorUniversity of Liege

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-06-01

Contact for this trial

Nicolas Piette, MD

003242843824 piettenicolas@me.com

View on ClinicalTrials.gov More Hemorrhage Postoperative trials